Beyond bisphosphonates: Thrombophilia, hypofibrinolysis, and jaw osteonecrosis

Journal of Oral and Maxillofacial Surgery

Volumn 64, Issue 11, 2006, Pages 1704-1705

  McMahon, Robert E ^a   Bouquot, Jerry E ^a   Glueck, Charles J ^a   Griep, John ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

BLOOD DISEASE; BONE NECROSIS; DISEASE ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HYPOFIBRINOLYSIS; JAW DISEASE; LETTER; MULTIPLE MYELOMA; THROMBOPHILIA;

BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FIBRINOLYSIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAW DISEASES; OSTEONECROSIS; RISK FACTORS; THROMBOPHILIA; THROMBOSIS;

EID: 33749678428     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2006.07.007     Document Type: Letter

References (23)

1. Kenzora J.E., and Glimcher M.J. Accumulative cell stress: The multifactorial etiology of idiopathic osteonecrosis. Orthop Clin North Am 16 (1985) 669
2. Cruess R.L. Osteonecrosis of bone. Clin Orthop Relat Res 208 (1986) 30
3. Jones J.P. Intravascular coagulation and osteonecrosis. Clin Orthop Relat Res 277 (1992) 41
4. Mankin J.H. Non-traumatic necrosis of bone (osteonecrosis). N Engl J Med 326 (1992) 1473
5. Urbaniak J.R., and Jones Jr. J.P. Osteonecrosis: Etiology, Diagnosis, and Treatment (1997), American Academy of Orthopaedic Surgeons, Rosemont, IL
6. Assael L.A. A time for perspective on bisphosphonates. J Oral Maxillofac Surg 64 (2006) 877
7. Hemostasis and coagulative disorders. In: Beers M.H., and Berkow R. (Eds). Merck Manual of Diagnosis and Treatment (1999), Merck Research Laboratories, Whitehouse Station, NJ 906
8. Glueck C.J., McMahon R.E., Bouquot J.E., et al. Thrombophilia, hypofibrinolysis and alveolar osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol 81 (1996) 557
9. Glueck C.J., McMahon R.E., Bouquot J.E., et al. Heterozygosity for the mutant Factor V Leiden gene: A common pathoetiology for osteonecrosis of the jaw. J Lab Clin Med 130 (1997) 540
10. McMahon R.E., Bouquot J.E., Glueck C.J., et al. Osteonecrosis: A multifactorial etiology, letter to editor. J Oral Maxillofac Surg 62 (2004) 904
11. Lensen R., Rosendaal F., Vandenbroucke J., et al. Factor V Leiden: The venous thrombotic risk in thrombophilic families. Br J Haematol 110 (2000) 939
12. Salgado A., Boveda J.L., Monasterio J., et al. Inflammatory mediators and their influence on haemostasis. Haemostasis 24 (1994) 132
13. Grau A.J., Becher H., Ziegler C.M., et al. Periodontal disease as a risk factor for ischemic stroke. Stroke 35 (2004) 496
14. Lerner U.H. Regulation of bone metabolism by the kallikrein-kinin system, the coagulation cascade, and the acute phase reactants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 78 (1994) 481
15. Grau A.J., Buggle F., Ziegler C., et al. Association between acute cerebrovascular ischemia and chronic and recurrent infection. Stroke 28 (1997) 1724
16. Wu O., Robertson L., Langhorne P., et al. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: A systematic review: The Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Thromb Haemost 94 (2005) 17
17. Vandenbroucks J.P., Koster T., Briet E., et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 344 (1994) 1453
18. Kaaja R.J., and Greer I.A. Manifestations of chronic disease during pregnancy. JAMA 294 (2005) 2751
19. Glueck C.J., McMahon R.E., Bouquot J.E., et al. Exogenous estrogen may exacerbate thrombophilia, impair bone healing, and contribute to development of chronic facial pain. Cranio 16 (1998) 143
20. Eby C.S. A review of the hypercoagulable state. Hematol Oncol Clin North Am 7 (1993) 1121
21. Heit J.A. Hereditary thrombotic diseases: Testing and management. Conference on Bleeding and Thrombosing Diseases: The Basics and Beyond (1997), Mayo Medical Laboratories, Rochester, MN August 1-2
22. Hook C.C. Acquired thrombotic diseases: Conference on Bleeding and Thrombosing Diseases: the Basics and Beyond (1997), Mayo Medical Laboratories, Rochester, MN August 1-2
23. Hammerschmidt D.E. Thrombophilic osteonecrosis: Another chapter. J Lab Clin Med 130 (1997) 451